+10 or trisomy 10 (solely)
+11 or trisomy 11 (solely) KMT2A
+14 or trisomy 14 (solely)
+19 or trisomy 19
+21 or trisomy 21
+22 or trisomy 22 (solely?)
+4 or trisomy 4
+6 or trisomy 6
+8 or trisomy 8
+9 or trisomy 9
+X solely in lymphomas
+X solely in myeloid malignancies
-20 or monosomy 20
-7/del(7q) in adults
8p11 myeloproliferative syndrome (FGFR1)
ABL1/PRRC2B (9q34)
Acute Lymphoblastic Leukemia with Hypereosinophilia
Acute myeloid leukemia with myelodysplasia related changes
Aggressive natural killer leukemia (ANKL)
ALK -positive diffuse large B-cell lymphoma
Alpha heavy chain disease
Anaplastic B-cell lymphoma
Anaplastic large cell lymphoma (ALCL)
Anaplastic large cell lymphoma, ALK-negative
Angioimmunoblastic T-cell lymphoma
Atypical Chronic Myeloid Leukemia (aCML)
B-cell prolymphocytic leukemia (B-PLL)
Biphenotypic Acute Leukaemia (BAL)
Burkitts lymphoma (BL)
Centroblastic lymphoma
Chronic Eosinophilic Leukemia-Not Otherwise Specified (CEL-NOS)
Idiopathic Hypereosinophilic Syndrome (IHES)
Chronic myelogenous leukaemia (CML)
Classical Hodgkin lymphoma
Classical Hodgkin lymphoma type PTLD
Classification of acute myeloid leukemias
Classification of Hodgkin lymphoma over years
Classification of T-Cell disorders
del (5q) solely in Myelodysplastic syndrome
del(13q) in myeloid malignancies
del(20q) in myeloid malignancies
del(5q) in myeloid neoplasms
del(9q) solely
Diffuse large cell lymphoma
Disseminated Juvenile Xanthogranuloma
DLBCL subtype: Extranodal lymphoma
Double Hit Lymphoma (DHL)
Triple Hit Lymphoma (THL)
Early T-cell precursor acute lymphoblastic leukemia
EBV positive DLBCL, NOS
Essential Thrombocythemia (ET)
Extranodal NK/T-cell lymphoma, nasal type (ENKL)
Florid follicular hyperplasia PTLD
Follicular dendritic cell in lymphomas of follicular origin
Follicular Dendritic Cell Sarcoma
Follicular lymphoma (FL)
Follicular lymphomas of germinal center (B- or T-cell) origin
Gamma heavy chain disease
Germinal center B-cell-like diffuse Large B-cell Lymphoma (GCB) DLBCL
Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia Variant (HCL-V)
Hepatosplenic T-cell lymphoma (HSTCL)
Histiocyte-rich B-cell lymphoma
Histiocytic Sarcoma
HIV-associated lymphomas
Hodgkin lymphoma
i(17q) solely in myeloid malignancies
Immunoblastic lymphoma
In situ follicular neoplasia
Indeterminate Dendritic Cell Tumor
Infectious mononucleosis-like PTLD
Interdigitating Dendritic Cell Sarcoma
Intestinal T-cell lymphoma
inv(10)(q11q11) NCOA4/RET
inv(16)(p13q22) CBFB/MYH11
t(16;16)(p13;q22) CBFB/MYH11
del(16)(q22) CBFB/MYH11
inv(3)(q21q26) RPN1/MECOMt(3;3)(q21;q26) RPN1/MECOMins(3;3)(q26;q21q26) RPN1/MECOM
Lymphoepithelioid lymphoma
Lymphoplasmacytic lymphoma
Mantle cell lymphoma
Mediastinal Gray Zone Lymphoma
Mixed phenotype acute leukemia (MPAL)
Monomorphic PTLD (B- and T/NK-cell types)
Mu heavy chain disease
Mucosa-associated lymphoid tissue (MALT) lymphoma
Multiple Myeloma
Multiple myeloma (published in 2004)
Mycosis fungoides/Sezarys syndrome
Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)
Myelodysplastic/myeloproliferative neoplasms
Myeloid sarcoma
Myeloid/Lymphoid neoplasms with abnormalities of PDGFRA
Myeloid/Lymphoid neoplasms with abnormalities of PDGFRB
Nodal marginal zone lymphoma (NMZL)
Nodular lymphocyte-predominant Hodgkin lymphoma
Nodular sclerosis classical Hodgkin lymphoma (NScHL)
Pediatric-type Follicular Lymphoma
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
Plasma cell leukemia (PCL)
Plasma Cell Neoplasms: an overview
Plasmacytoma (Solitary bone plasmacytoma, extramedullary plasmacytoma)
Polyclonal B Lymphocytosis with Binucleated Lymphocytes (PPBL)
Polymorphic PTLD
Primary cutaneous CD30+ anaplastic large cell lymphoma
Primary cutaneous DLBCL, leg type
Primary DLBCL of the central nervous system (CNS)
Primary mediastinal B-cell lymphoma (PMBL)
Refractory anemia with ringed sideroblasts (RARS)
Small lymphocytic lymphoma
Splenic lymphoma with villous lymphocytes (SLVL) in 2005
Subcutaneous panniculitis-like T-cell lymphoma
Systemic mast cell disease (SMCD)
t(10;11)(p12;q21) PICALM/MLLT10
t(10;11)(p12;q23) KMT2A/MLLT10
t(11;12)(p15;q13) NUP98/RARG
t(11;17)(q23;q12-21) KMT2A/MLLT6
t(11;17)(q23;q21) ZBTB16/RARA
t(11;19)(q23;p13.1) KMT2A/ELL
t(11;19)(q23;p13.3) KMT2A/MLLT1
t(12;22)(p13;q12) MN1/ETV6
t(14;22)(q32;q11) IGH/IGL
t(15;17)(q24;q21) PML/RARA
t(16;21)(p11;q22) FUS/ERG
t(17;17)(q21;q21) STAT5B/RARA
dup(17)(q12q21) STAT5B/RARA
t(1;11)(p32;q23) KMT2A/EPS15
t(1;11)(q21;q23) KMT2A/MLLT11
t(1;3)(p36;q21) PSMD2/PRDM16 ???
t(2;11)(p21;q23) KMT2A/?
t(3;12)(q26;p13) ETV6/MECOM
t(3;12)(q26;p13) ETV6/EVI1
t(3;21)(q26;q22) RUNX1/MECOM
t(3;5)(q25;q34) NPM1/MLF1
t(4;11)(q21;q23) KMT2A/AFF1
t(4;12)(q12;p13) CHIC2/ETV6
t(5;12)(q33;p13) ETV6/PDGFRB
t(5;17)(q35;q21) NPM1/RARA
t(5;7)(q33;q11) HIP1/PDGFRB
t(6;11)(q27;q23) KMT2A/AFDN
t(6;8)(q27;p12) FGFR1OP/FGFR1
t(6;9)(p22;q34) DEK/NUP214
t(7;11)(p15;p15) NUP98/HOXA9
t(8;14)(q11;q32) IGH/CEBPD
t(8;16)(p11;p13) KAT6A/CREBBP
t(8;21)(q22;q22) RUNX1/RUNX1T1
t(9;12)(q34;p13) ETV6/ABL1
t(9;22)(q34;q11) BCR/ABL1 in ALL
t(9;22)(q34;q11) BCR/ABL1 in CML
T-cell large granular lymphocyte leukaemia
T-cell prolymphocytic leukemia (T-PLL)
T-cell/histiocyte rich large B-cell lymphoma
Waldenstrom macroglobulinemia
Y loss in leukemia